Artiva Biotherapeutics, Inc. | License Agreements | Business Contracts

First Amendment to License Agreement, dated May 9, 2022, by and between the Registrant and ARE-SD Region No. 37, LLC (Filed With SEC on June 6, 2022)

Option and License Agreement, dated September 4, 2019, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)

Amendment No. 1 to Option and License Agreement, dated June 23, 2020, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)

Selected Product License Agreement (AB-101), dated November 21, 2019, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)

Selected Product License Agreement (AB-201), dated September 29, 2020, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)

Merck Partnered Product Research Services and License Agreement, dated January 27, 2021, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)

Selected Product License Agreement (AB-202), dated March 24, 2021, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)

Artiva Biotherapeutics, Inc. (37) | License Agreements (7)